- Latest available (Revised)
- Point in Time (18/10/2005)
- Original (As adopted by EU)
Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 19/11/2005
Point in time view as at 18/10/2005.
There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed),
ANNEX III
.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Textual Amendments
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Clorsulon | Clorsulon | Bovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
150 μg/kg | Liver | ||||
400 μg/kg | Kidney |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Clavulanic acid | Clavulanic acid | Bovine, ovine | 200 μg/kg | Milk | [F2Provisional MRLs expire on 1 July 2001] |
Bovine, ovine, porcine | 200 μg/kg | Muscle | |||
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney |
Textual Amendments
F2 Substituted by Commission Regulation (EC) No 1943/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
a [F3Provisional MRLs expire on 1 July 2006 . | |||||
b Not for use in animals from which eggs are produced for human consumption.] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F4Acetylisovaleryltylosin | Sum of acetylisovaleryltylosin and 3-O-acetyltylosin | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
100 μg/kg | Skin and fat | ||||
100 μg/kg | Liver | ||||
100 μg/kg | Kidney] | ||||
[F3Acetylisovaleryltylosin a | Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin | Poultry b | 50 μg/kg | Skin and fat | |
50 μg/kg | Liver | ] | |||
Erythromycin | MRLs apply to all microbiological active residues expressed as erythromycin equivalent | Bovine, ovine | 40 μg/kg | Milk | Provisional MRLs expire on 1 June 2000 |
Bovine, ovine, porcine, poultry | 400 μg/kg | Muscle | |||
400 μg/kg | Fat | ||||
400 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
Poultry | 200 μg/kg | Eggs | |||
Josamycin | Josamycin | Chicken | 200 μg/kg | Muscle | [F5Provisional MRLs expire on 1.7.2002] |
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
200 μg/kg | Eggs | ||||
[F6 | Sum of the microbiologically active metabolites, expressed as josamycin | Porcine | 200 μg/kg | Muscle | Provisional MRLs expire on 1.7.2002 |
200 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
400 μg/kg | Kidney] | ||||
[F7Tilmicosin | Tilmicosin | Bovine | 40 μg/kg | Milk | Provisional MRLs expire on 1.1.2001] |
[F8Tulathromycin | (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents | Bovine | 100 μg/kg | Fat | Provisional MRLs expire on 1 July 2004 ; not for use in animals from which milk is produced for human consumption |
3 000 μg/kg | Liver | ||||
3 000 μg/kg | Kidney | ||||
Porcine | 100 μg/kg | Skin and fat | Provisional MRLs expire on 1 July 2004 | ||
3 000 μg/kg | Liver | ||||
3 000 μg/kg | Kidney] |
Textual Amendments
F3 Inserted by Commission Regulation (EC) No 75/2005 of 18 January 2005 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards moxidectin, linear alkyl benzene sulphonic acids with alkyl chain lengths ranging from C9 to C13, containing less than 2,5 % of chains longer than C13 and Acetylisovaleryltylosin (Text with EEA relevance).
F4 Inserted by Commission Regulation (EC) No 1286/2000 of 19 June 2000 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F5 Substituted by Commission Regulation (EC) No 2338/2000 of 20 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F6 Inserted by Commission Regulation (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F7 Inserted by Commission Regulation (EC) No 2593/1999 of 8 December 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F8 Inserted by Commission Regulation (EC) No 1937/2002 of 30 October 2002 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Cefacetrile | Cefacetrile | Bovine | 125 μg/kg | Milk | [F10Provisional MRLs expire on 1.1.2002] For intrammamary use only |
[F11Cefalonium | Cefalonium | Bovine | 10 μg/kg | Milk | [F12Provisional MRLs expire on 1.1.2003] ] |
[F13Cefoperazone | Cefoperazone | Bovine | 50 μg/kg | Milk | Provisional MRLs expire on 1 January 2001] |
[F14Cefquinome | Cefquinome | Porcine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2000 |
50 μg/kg | Skin + fat | ||||
100 μg/kg | Liver | ||||
200 μg/kg | Kidney] | ||||
Cephapirin | Sum of cephapirin and desacetylcephapirin | Bovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
10 μg/kg | Milk] |
Textual Amendments
F10 Substituted by Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F11 Inserted by Commission Regulation (EC) No 2728/1999 of 20 December 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F12 Substituted by Commission Regulation (EC) No 1322/2001 of 29 June 2001 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F13 Inserted by Commission Regulation (EC) No 1943/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
F9 Inserted by Commission Regulation (EC) No 804/1999 of 16 April 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Aminosidine | Aminosidine | Bovine, porcine, rabbits, chicken | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
1 500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
Apramycin | Apramycin | Bovine | 1 000 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
For use in non-lactating cattle only | 1 000 μg/kg | Fat | |||
10 000 μg/kg | Liver | ||||
20 000 μg/kg | Kidney | ||||
Porcine | 1 000 μg/kg | Muscle | |||
1 000 μg/kg | Skin and fat | ||||
1 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
[F15Dihydrostreptomycin | Dihydrostreptomycin | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
200 μg/kg | Milk | ||||
Porcine | 500 μg/kg | Muscle | |||
500 μg/kg | Skin and fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Gentamicin | Gentamicin | Bovine | 100 μg/kg | Milk | Provisional MRLs expire on 1.6.2002 |
Bovine, porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
750 μg/kg | Kidney] | ||||
[F16Kanamycin | Kanamycin | Rabbits | 100 μg/kg | Muscle | [F17Provisional MRLs expire on 1.1.2004] |
100 μg/kg | Fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney | ||||
Bovine, ovine | 100 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney | ||||
150 μg/kg | Milk | ||||
Porcine, chicken | 100 μg/kg | Muscle | |||
100 μg/kg | Skin + fat | ||||
600 μg/kg | Liver | ||||
2 500 μg/kg | Kidney] | ||||
[F15Neomycin (including framycetin) | Neomycin B | Bovine, porcine, chicken | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
Bovine | 500 μg/kg | Milk | |||
Chicken | 500 μg/kg | Eggs] | |||
Spectinomycin | Spectinomycin | Bovine | 200 μg/kg | Milk | Provisional MRLs expire on 1 July 2000 |
Bovine, porcine, poultry | 300 μg/kg | Muscle | |||
500 μg/kg | Fat | ||||
2 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
[F11 | Ovine Not for use in animals from which milk is produced for human consumption | 300 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 | |
500 μg/kg | Fat | ||||
2 000 μg/kg | Liver | ||||
5 000 μg/kg | Kidney | ||||
Chicken | 200 μg/kg | Eggs] | |||
[F15Streptomycin | Streptomycin | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1.6.2002 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
200 μg/kg | Milk | ||||
Porcine | 500 μg/kg | Muscle | |||
500 μg/kg | Skin and fat | ||||
500 μg/kg | Liver | ||||
1 000 μg/kg | Kidney] |
Textual Amendments
F15 Substituted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F16 Inserted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F17 Substituted by Commission Regulation (EC) No 2162/2001 of 7 November 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
a [F18Provisional MRLs expire 1 January 2006 . | |||||
b Not for use in animals from which milk is produced for human consumption.] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F6Danofloxacin | Danofloxacin | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2000 |
50 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney] | ||||
Decoquinate | Decoquinate | Bovine, ovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
500 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
500 μg/kg | Kidney | ||||
[F19Difloxacin | Difloxacin | Bovine Not for use in animals from which milk is produced for human consumption | 400 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
100 μg/kg | Fat | ||||
1 400 μg/kg | Liver | ||||
800 μg/kg | Kidney | ||||
Porcine | 400 μg/kg | Muscle | |||
100 μg/kg | Skin and fat | ||||
800 μg/kg | Liver | ||||
800 μg/kg | Kidney] | ||||
Enrofloxacin | Sum of enrofloxacin and ciprofloxacin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1 July 1999 |
100 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Flumequine | Flumequine | Bovine, ovine, porcine, chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
50 μg/kg | Fat or skin and fat | ||||
100 μg/kg | Liver | ||||
300 μg/kg | Kidney | ||||
Salmonidae | 150 μg/kg | Muscle and skin | |||
Marbofloxacin | Marbofloxacin | Bovine | 150 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
50 μg/kg | Fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
75 μg/kg | Milk | ||||
Porcine | 150 μg/kg | Muscle | |||
50 μg/kg | Skin and fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
[F9 [F20Oxolinic acid a | Oxolinic acid | Bovine b | 100 µg/kg | Muscle | |
50 µg/kg | Fat | ||||
150 µg/kg | Liver | ||||
150 µg/kg | Kidney] | ||||
Porcine | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
Chicken | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
Fin fish | 300 μg/kg | Muscle and skin in natural proportions] |
Textual Amendments
F18 Inserted by Commission Regulation (EC) No 546/2004 of 24 March 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F19 Inserted by Commission Regulation (EC) No 997/1999 of 11 May 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F20 Substituted by Commission Regulation (EC) No 546/2004 of 24 March 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Phamarcologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Colistin | Colistin | Bovine, ovine | 50 μg/kg | Milk | [F5Provisional MRLs expire on 1.7.2002] |
Bovine, ovine, porcine, chicken, rabbits | 150 μg/kg | Muscle | |||
150 μg/kg | Fat | ||||
150 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
Chicken | 300 μg/kg | Eggs |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F9Nafcillin | Nafcillin | Bovine | 300 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
300 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
300 μg/kg | Kidney | ||||
30 μg/kg | Milk] | ||||
Penethamate | Benzylpenicillin | Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
4 μg/kg | Milk | ||||
Porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney |
a [F21Provisional MRLs expire on 1 January 2007 .] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Florfenicol | Sum of florfenicol and its metabolites measured as florfenicol-amine | Fish | 1 000 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 2001 |
[F9Thiamphenicol | Thiamphenicol | Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
Porcine | 50 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
Fin fish | 50 μg/kg | Muscle and skin in natural proportions] | |||
[F21Thiamphenicol a | Thiamphenicol | Porcine | 50 μg/kg | Muscle | |
50 μg/kg | Skin + fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ] |
Textual Amendments
F21 Inserted by Commission Regulation (EC) No 1299/2005 of 8 August 2005 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards phenoxymethylpenicillin, phoxim, norgestomet and thiamphenicol (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Bacitracin | Bacitracin | Bovine | 150 μg/kg | Milk | Provisional MRLs expire on 1.7.2001] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Lincomycin | Lincomycin | Ovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
150 μg/kg | Milk | ||||
Porcine | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
Chicken | 100 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
500 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
[F6Pirlimycin | Pirlimycin | Bovine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2000 |
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
100 μg/kg | Milk] ] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Tiamulin | Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin | Turkey | 100 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
100 μg/kg | Skin and fat | ||||
300 μg/kg | Liver] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Oxyclozanide | Oxyclozanide | Bovine | 20 μg/kg | Muscle | [F5Provisional MRLs expire on 1.7.2002] |
20 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
10 μg/kg | Milk | ||||
Ovine | 20 μg/kg | Muscle | |||
20 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
100 μg/kg | Kidney] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Albendazole sulphoxide | Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole | Bovine, ovine | 100 μg/kg | Milk | Provisional MRLs expire on 1 January 2000 |
Bovine, ovine, pheasant | 100 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
500 μg/kg | Kidney | ||||
[F11Mebendazole | Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents | Ovine, caprine, equidae Not for use in animals from which milk is produced for human consumption | 60 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 |
60 μg/kg | Fat | ||||
400 μg/kg | Liver | ||||
60 μg/kg | Kidney] | ||||
Netobimin | Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone | Bovine, ovine, caprine | 100 μg/kg | Muscle | Provisional MRLs expire on 31 July 1999 |
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
500 μg/kg | Kidney | ||||
100 μg/kg | Milk |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Morantel | Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents | Bovine, ovine | 100 μg/kg | Muscle | [F12Provisional MRLs expire on 1.7.2003] |
100 μg/kg | Fat | ||||
800 μg/kg | Liver | ||||
200 μg/kg | Kidney | ||||
100 μg/kg | Milk | ||||
Porcine | 100 μg/kg | Muscle | |||
100 μg/kg | Skin and fat | ||||
800 μg/kg | Liver | ||||
200 μg/kg | Kidney] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Piperazine | Piperazine | Porcine | 400 μg/kg | Muscle | [F22Provisional MRLs expire on 1.7.2003] |
800 μg/kg | Skin and fat | ||||
2 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Chicken | 2 000 μg/kg | Eggs] |
Textual Amendments
F22 Substituted by Commission Regulation (EC) No 1478/2001 of 18 July 2001 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Rafoxanide | Rafoxanide | Bovine Not for use in animals from which milk is produced for human consumption | 30 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
30 μg/kg | Fat | ||||
10 μg/kg | Liver | ||||
40 μg/kg | Kidney | ||||
Ovine Not for use in animals from which milk is produced for human consumption | 100 μg/kg | Muscle | |||
250 μg/kg | Fat | ||||
150 μg/kg | Liver | ||||
150 μg/kg | Kidney] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Amitraz | Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz | Bees | 200 μg/kg | Honey | Provisional MRLs expire on 1 July 1999 |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Cymiazole | Cymiazole | Bees | 1 000 μg/kg | Honey | [F23Provisional MRLs expire on 1.7.2001] |
Textual Amendments
F23 Substituted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
a [F24Provisional MRLs expire on 1 July 2006 .] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Cyfluthrin | Cyfluthrin | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1 January 2001 |
50 μg/kg | Fat | ||||
10 μg/kg | Liver | ||||
10 μg/kg | Kidney | ||||
20 μg/kg | Milk | ||||
Further provisions in Council Directive 94/29/EC are to be observed ( OJ L 189, 23.7.1994, p. 67 ) | |||||
[F14Alphacypermethrin | Cypermethrin (sum of isomers) | Bovine, ovine | 20 μg/kg | Muscle | [F25Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed] |
200 μg/kg | Fat | ||||
20 μg/kg | Liver | ||||
20 μg/kg | Kidney | ||||
20 μg/kg | Milk [F26Further provisions in Council Directive 93/57/EC ( OJ L 211, 23.8.1992, p. 1 ) are to be observed] | ||||
Chicken | 50 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
[F25Cypermethrin | Cypermethrin (sum of isomers) | Bovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed |
200 μg/kg | Fat | ||||
20 μg/kg | Liver | ||||
20 μg/kg | Kidney | ||||
20 μg/kg | Milk | ||||
Cypermethrin (sum of isomers) | Ovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003 Not for use in animals from which milk is produced for human consumption | |
200 μg/kg | Fat | ||||
20 μg/kg | Liver | ||||
20 μg/kg | Kidney] | ||||
Porcine | 20 μg/kg | Muscle | |||
200 μg/kg | Skin + fat | ||||
20 μg/kg | Liver | ||||
20 μg/kg | Kidney | ||||
Chicken | 50 μg/kg | Muscle | |||
50 μg/kg | Skin + fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
Salmonidae | 50 μg/kg | Muscle and skin in natural proportions | [F27Provisional MRLs expire on 1.7.2003] ] | ||
[F28Deltamethrin | Deltamethrin | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1 July 2001 |
50 μg/kg | Fat | ||||
10 μg/kg | Liver | ||||
10 μg/kg | Kidney | ||||
20 μg/kg | Milk | ||||
Ovine Not for use in animals from which milk is produced for human consumption | 10 μg/kg | Muscle | |||
50 μg/kg | Fat | ||||
10 μg/kg | Liver | ||||
10 μg/kg | Kidney | ||||
Chicken | 10 μg/kg | Muscle | [F29Provisional MRLs expire on 1.7.2003] | ||
50 μg/kg | Skin + fat | ||||
10 μg/kg | Liver | ||||
10 μg/kg | Kidney | ||||
50 μg/kg | Eggs | ||||
[F30 | Fin fish | 10 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1.1.2002] ] | |
[F31Fenvalerate a | Fenvalerate (sum of RR, SS, RS and SR isomers) | Bovine | 25 μg/kg | Muscle | |
250 μg/kg | Fat | ||||
25 μg/kg | Liver | ||||
25 μg/kg | Kidney | ||||
40 μg/kg | Milk] | ||||
[F10Permethrin | Permethrin (sum of isomers) | Chicken, porcine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2003 |
500 μg/kg | Skin and fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
Bovine, caprine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.1.2003 | ||
500 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
50 μg/kg | Milk | Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 ) | |||
Chicken | 50 μg/kg | Eggs | Provisional MRLs expire on 1.1.2003] |
Textual Amendments
F24 Inserted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).
F25 Substituted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F26 Deleted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F27 Inserted by Commission Regulation (EC) No 77/2002 of 17 January 2002 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F28 Inserted by Commission Regulation (EC) No 1942/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F29 Inserted by Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F30 Inserted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F31 Substituted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Azamethiphos | Azamethiphos | Salmonidae | 100 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 June 1999 |
[F16Coumafos | Coumafos | Bees | 100 μg/kg | Honey | Provisional MRLs expire on 1.7.2001] |
[F32Phoxim | Phoxim | Porcine | 20 μg/kg | Muscle | Provisional MRLs expire on 1 January 2001 |
700 μg/kg | Skin and fat | ||||
20 μg/kg | Liver | ||||
20 μg/kg | Kidney | ||||
[F33Ovine | 50 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 ; not for use in animals from which milk is produced for human consumption | ||
400 μg/kg | Fat | ||||
50 μg/kg | Kidney] | ||||
[F34Chicken | 50 μg/kg | Muscle | Provisional MRLs expire on 1.7.2005 . | ||
550 μg/kg | Skin and fat | ||||
25 μg/kg | Liver | ||||
50 μg/kg | Kidney | ||||
60 μg/kg | Eggs] ] | ||||
[F11Propetamphos | Sum of residues of propetamphos and desisopropyl-propetamphos | Ovine Not for use in animals from which milk is produced for human consumption | 90 μg/kg | Fat | Provisional MRLs expire on 1.1.2001 |
90 μg/kg | Kidney] |
Textual Amendments
F32 Inserted by Commission Regulation (EC) No 2385/1999 of 10 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F33 Inserted by Commission Regulation (EC) No 2391/2000 of 27 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F34 Inserted by Commission Regulation (EC) No 2011/2003 of 14 November 2003 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Teflubenzuron | Teflubenzuron | Salmonidae | 500 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1 July 1999 |
[F19Diflubenzuron | Diflubenzuron | Salmonidae | 1 000 μg/kg | Muscle and skin in natural proportions | Provisional MRLs expire on 1.7.2000] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Dicyclanil | Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile | Ovine | 200 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 ; Not for use in animals from which milk is produced for human consumption |
50 μg/kg | Fat | ||||
400 μg/kg | Liver | ||||
400 μg/kg | Kidney] |
Textual Amendments
F35 Inserted by Commission Regulation (EC) No 2393/1999 of 11 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Cyromazine | Cyromazine | Ovine | 300 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 Not for use in animals from which milk is produced for human consumption |
300 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
300 μg/kg | Kidney] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F11Abamectin | Avermectin B1a | Ovine | 20 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
50 μg/kg | Fat | ||||
25 μg/kg | Liver | ||||
20 μg/kg | Kidney | ||||
Doramectin | Doramectin | Deer, inclusing reindeer | 20 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 |
100 μg/kg | Fat | ||||
50 μg/kg | Liver | ||||
30 μg/kg | Kidney] | ||||
Moxidectin | Moxidectin | Equidae | 50 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
500 μg/kg | Fat | ||||
100 μg/kg | Liver | ||||
50 μg/kg | Kidney |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Imidocarb | Imidocarb | Bovine, ovine | 300 μg/kg | Muscle | Provisonal MRLs expire on 1.1.2002 |
50 μg/kg | Fat | ||||
2 000 μg/kg | Liver | ||||
1 500 μg/kg | Kidney | ||||
50 μg/kg | Milk |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Halofuginone | Halofuginone | Bovine | 10 μg/kg | Muscle | Provisional MRL's expire on 1.1.2001 |
25 μg/kg | Fat | ||||
30 μg/kg | Liver | ||||
30 μg/kg | Kidney] |
a [F36Provisional MRLs expire on 1 July 2006 . Not for use in animals from which milk is produced for human consumption.] ] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Toltrazuril | Toltrazuril sulfone | Porcine | 100 μg/kg | Muscle | Provisional MRLs expire on 1.1.2001 |
150 μg/kg | Skin and fat | ||||
500 μg/kg | Liver | ||||
250 μg/kg | Kidney | ||||
[F36Toltrazuril a | Toltrazuril sulfone | Bovine | 100 μg/kg | Muscle | |
150 μg/kg | Fat | ||||
500 μg/kg | Liver | ||||
250 μg/kg | Kidney] |
Textual Amendments
F36 Inserted by Commission Regulation (EC) No 2232/2004 of 23 December 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRL | Target tissues | Other provisions |
---|---|---|---|---|---|
Amprolium | Amprolium | Chicken, turkey | 200 μg/kg | Muscle | Provisional MRLs expire on 1.1.2002 |
200 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
400 μg/kg | Kidney | ||||
1 000 μg/kg | Eggs] ] |
Textual Amendments
F37 Inserted by Commission Regulation (EC) No 1295/2000 of 20 June 2000 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Clenbuterol hydrochloride | Clenbuterol | Bovine | 0,1 μg/kg | Muscle | Provisional MRLs expire on 1 July 2000 |
Indication: solely for tocolysis in parturient cows | 0,5 μg/kg | Liver | |||
0,5 μg/kg | Kidney | ||||
0,05 μg/kg | Milk | ||||
Equidae | 0,1 μg/kg | Muscle | |||
Indications: tocolysis and the treatment of respiratory ailments | 0,5 μg/kg | Liver | |||
0,5 μg/kg | Kidney |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Carazolol | Carazolol | Bovine | 5 μg/kg | Muscle | Provisional MRLs expire on 1.1.2000 |
5 μg/kg | Fat | ||||
15 μg/kg | Liver | ||||
15 μg/kg | Kidney | ||||
1 μg/kg | Milk] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Carprofen | Carprofen | Bovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
500 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Equidae | 50 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Meloxicam | Meloxicam | Bovine | 25 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
60 μg/kg | Liver | ||||
35 μg/kg | Kidney |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F12Metamizole | 4-Methylaminoantipyrin | Bovine, porcine, equidae | 200 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003 . Not for use in animals from which milk is produced for human consumption |
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney] ] |
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Altrenogest | Altrenogest | Porcine | 3 μg/kg | [F39Skin and fat] | [F39Provisional MRLs expire on 1.1.2005 ; for zootechnical use only] |
3 μg/kg | Liver | ||||
3 μg/kg | Kidney | ||||
Equidae | 3 μg/kg | Fat | |||
3 μg/kg | Liver | ||||
3 μg/kg | Kidney | ||||
[F40Flugestone acetate | Flugestone acetate | Ovine, caprine | 0,5 μg/kg | Muscle | Provisional MRLs expire on 1.1.2008 ; for therapeutic or zootechnical use only |
0,5 μg/kg | Fat | ||||
0,5 μg/kg | Liver | ||||
0,5 μg/kg | Kidney | ||||
Norgestomet | Norgestomet | Bovine | 0,5 μg/kg | Muscle | Provisional MRLs expire on 1.1.2008 ; for therapeutic or zootechnical use only |
0,5 μg/kg | Fat | ||||
0,5 μg/kg | Liver | ||||
0,5 μg/kg | Kidney | ||||
0,15 μg/kg | Milk] ] |
Textual Amendments
F39 Substituted by Commission Regulation (EC) No 1530/2002 of 27 August 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F40 Substituted by Commission Regulation (EC) No 665/2003 of 11 April 2003 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Textual Amendments
F38 Inserted by Council Regulation (EC) No 2584/2001 of 19 December 2001 amending Annexes I and III of Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Methylprednisolone | Methylprednisolone | Bovine | 10 μg/kg | Muscle | Provisional MRLs expire on 1.7.2001 . Not for use in animals from which milk is produced for human consumption |
10 μg/kg | Fat | ||||
10 μg/kg | Liver | ||||
10 μg/kg | Kidney] ] |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: